Nesrine Anaya-Ben

Hamburg, HH, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Reduction of impairment of sexual activity in patients with genital psoriasis treated with risankizumab: interim results of a real-world study.

Reduction of impairment of sexual activity in patients with genital psoriasis treated with risankizumab: interim results of a real-world study.

Journal: The Journal of dermatological treatment

Published: November 27, 2025

Effective management of psoriasis and psoriatic arthritis in a patient with systemic lupus erythematosus using deucravacitinib, mycophenolate mofetil and hydroxychloroquine.

Effective management of psoriasis and psoriatic arthritis in a patient with systemic lupus erythematosus using deucravacitinib, mycophenolate mofetil and hydroxychloroquine.

Journal: Skin health and disease

Published: October 02, 2025

Epidemiology and Health Care of Generalized Pustular Psoriasis in Germany - Methodology and Outcomes of Claims Data Analysis.

Epidemiology and Health Care of Generalized Pustular Psoriasis in Germany - Methodology and Outcomes of Claims Data Analysis.

Journal: Psoriasis (Auckland, N.Z.)

Published: March 20, 2025

Systemic Therapy of Psoriasis in Children-Proposal of an Algorithm for Interdisciplinary Teamwork.

Systemic Therapy of Psoriasis in Children-Proposal of an Algorithm for Interdisciplinary Teamwork.

Journal: Journal of clinical medicine

Published: September 03, 2024

Basic Susceptibility of Patients with Psoriasis under Systemic Therapy for Respiratory Infections: Data from the German Psoriasis Registry PsoBest.

Basic Susceptibility of Patients with Psoriasis under Systemic Therapy for Respiratory Infections: Data from the German Psoriasis Registry PsoBest.

Journal: Journal of clinical medicine

Published: April 29, 2024

Real-world outcomes and drug survival of brodalumab: results from the German Psoriasis Registry PsoBest.

Real-world outcomes and drug survival of brodalumab: results from the German Psoriasis Registry PsoBest.

Journal: The Journal of dermatological treatment

Published: April 18, 2024

Quality of life, disease burden and healthcare need of patients with vitiligo

Quality of life, disease burden and healthcare need of patients with vitiligo

Journal: Dermatologie (Heidelberg, Germany)

Published: January 24, 2024

Epidemiology of alopecia areata and population-wide comorbidities in Germany: analysis of longitudinal claims data.

Epidemiology of alopecia areata and population-wide comorbidities in Germany: analysis of longitudinal claims data.

Journal: The British journal of dermatology

Published: July 21, 2023

Switching from Adalimumab Originator to Biosimilar in Patients with Hidradenitis Suppurativa Results in Losses of Response-Data from the German HS Registry HSBest.

Switching from Adalimumab Originator to Biosimilar in Patients with Hidradenitis Suppurativa Results in Losses of Response-Data from the German HS Registry HSBest.

Journal: Life (Basel, Switzerland)

Published: August 29, 2022

Response to fumaric acid esters for plaque type psoriasis in real-world practice is largely independent of patient characteristics at baseline - a multivariable regression analysis from the German Psoriasis Registry PsoBest.

Response to fumaric acid esters for plaque type psoriasis in real-world practice is largely independent of patient characteristics at baseline - a multivariable regression analysis from the German Psoriasis Registry PsoBest.

Journal: The Journal of dermatological treatment

Published: August 18, 2022

Showing 1-10 of 10

Last Updated: 09/26/2026